In the sphere of immuno-oncology research, a powerful tool has emerged - the Diet-Induced Obesity (DIO) mouse model. These models provide researchers a practical route to understanding the connections between obesity, immunity, and cancer treatment. The real value of DIO mice lies in their ability to reflect human-like responses, marking a new phase of discovery. Below are the top 5 reasons researchers should be incorporating DIO mice into the preclinical evaluation of immuno-oncology treatments.
August 22, 2023
- Fluorescent Cell Barcoding Using Flow Cytometry For High Throughput Testing
- Flow Cytometry Processing and Analysis of Tumor Specimens: Testing Viability and Staining Post Shipping
- The Importance of Conducting PDX Oncology Studies in a Humanized Immune System
- Leveraging Flow Cytometry to Drive Better Patient Outcomes in Hematologic Malignancy Clinical Trials
- The Importance of Incorporating Metabolomic and Proteomic Screening in Preclinical Oncology Studies
Fluorescent Cell Barcoding Using Flow Cytometry For High Throughput Testing
By Rubina Pal, PhD, Flow Cytometry Scientist
Flow Cytometry Processing and Analysis of Tumor Specimens: Testing Viability and Staining Post Shipping
By Hillary Reif, Administrative Assistant/Research Associate I and Christine Samuelson, Administrative Assistant
The Importance of Conducting PDX Oncology Studies in a Humanized Immune System
Preclinical oncology studies are a critical step in developing effective cancer therapies. Patient-derived xenograft (PDX) models have become a ...
Get Started
Contact Us Today!
If you’re looking for an expert team to guide your trial with efficiency in mind, we can help. As the creators of the Dynamic Trial, TD2 provides start-to-finish support with trial strategy, design and execution for faster go-to-market potential.
